Evidence map›Paper›PMID 42513112›Full record

ArticleMolecules (Basel, Switzerland)2026

Green Synthesis Characterization and Evaluation of

Rebotile M Machika, Joshua O Olowoyo, Malohle D Tswaledi, Kokoette Bassey

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rebotile M MachikaDepartment of Pharmaceutical Sciences, School of Pharmacy, Sefako Makgatho Health Sciences University, P.O. Box 218, Pretoria 0208, South Africa.
Joshua O OlowoyoDepartment of Health Sciences, Marieb College of Health and Human Services, Florida Gulf Coast University, 10501 FGCU Blvd, Fort Myers, FL 33965, USA.
Malohle D TswalediDepartment of Biochemistry and Biotechnology, School of Science and Technology, Sefako Makgatho Health Sciences University, P.O. Box 218, Pretoria 0208, South Africa.ORCID 0000-0002-9960-5565
Kokoette BasseyDepartment of Pharmaceutical Sciences, School of Pharmacy, Sefako Makgatho Health Sciences University, P.O. Box 218, Pretoria 0208, South Africa.ORCID 0000-0001-8178-1221

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigated the antiviral potential of silver nanoparticles (AgNPs) synthesized from

Indexed as

Antiviral AgentsCoronavirus Papain-Like ProteasesMetal NanoparticlesPlant ExtractsSARS-CoV-2Senna PlantSilverAnimalsCell SurvivalChlorocebus aethiopsGreen Chemistry TechnologyVero CellsAntiviral AgentsCoronavirus Papain-Like ProteasesPlant ExtractsSilverantiviral assaycytotoxicityphytochemicalsSARS-CoV-2 PLproSenna italicasilver nanoparticlesVepris reflexa

Identifiers

PMID42513112
PMCPMC13413824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.